• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1p36.1区域的DNA拷贝数缺失,该区域含有RUNX3,伴有启动子高甲基化以及肝吸虫相关性肝内胆管癌中RUNX3表达缺失。

DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.

作者信息

Dachrut Somkid, Banthaisong S, Sripa M, Paeyao A, Ho C, Lee S A, Kosinski C, Patil M A, Zhang J, Chen X, Sripa Banchob, Pairojkul Chawalit

机构信息

Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

出版信息

Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):575-82.

PMID:19827872
Abstract

Runt-related transcription factor 3 (RUNX3) is a candidate tumor suppressor gene, localized on 1p36, involved in TGF-beta-Smads signaling. To assess its role in liver fluke-associated intrahepatic cholangiocarcinoma (ICC), the promoter methylation status was investigated in 53 ICCs by methylation-specific PCR, with determination of loss of 1p36.1 by microarray comparative genomic hybridization and RUNX3 protein expression by immunohistochemistry. Loss at 1p36.1 was found 41.5% of ICCs (22/53). In addition, DNA hypermethylation of the RUNX3 promoter was found in 49.1% (26/53) of cancers and 57.1% (4/7) of ICC cell lines. The protein was highly expressed in normal bile ducts but mostly decreased in ICCs, 67.9% (n= 36) being negative for immunohistochemical staining. Promoter hypermethylation of RUNX3 was associated with reversible decrease or absence of RUNX3 protein expression (p<0.001), but this was not found to differ with the ICC subtype. In contrast, loss of 1p36.1 demonstrated a significant link (p= 0.020). In conclusion, RUNX3 promoter hypermethylation and loss of 1p36.1 are causal mechanisms for loss of RUNX3 function in liver fluke-associated ICC carcinogenesis.

摘要

runt相关转录因子3(RUNX3)是一种候选肿瘤抑制基因,定位于1p36,参与转化生长因子-β-Smads信号传导。为评估其在肝吸虫相关肝内胆管癌(ICC)中的作用,通过甲基化特异性PCR对53例ICC进行启动子甲基化状态研究,通过微阵列比较基因组杂交确定1p36.1缺失,并通过免疫组织化学检测RUNX3蛋白表达。在41.5%(22/53)的ICC中发现1p36.1缺失。此外,在49.1%(26/53)的癌症和57.1%(4/7)的ICC细胞系中发现RUNX3启动子DNA高甲基化。该蛋白在正常胆管中高表达,但在ICC中大多降低,67.9%(n = 36)免疫组织化学染色呈阴性。RUNX3启动子高甲基化与RUNX3蛋白表达可逆性降低或缺失相关(p<0.001),但未发现其在ICC亚型间存在差异。相比之下,1p36.1缺失显示出显著关联(p = 0.020)。总之,RUNX3启动子高甲基化和1p36.1缺失是肝吸虫相关ICC致癌过程中RUNX3功能丧失的因果机制。

相似文献

1
DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.1p36.1区域的DNA拷贝数缺失,该区域含有RUNX3,伴有启动子高甲基化以及肝吸虫相关性肝内胆管癌中RUNX3表达缺失。
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):575-82.
2
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.1p36区域的频繁半合子缺失和高甲基化下调了人肺癌细胞系中RUNX3的表达。
Oncol Rep. 2005 Oct;14(4):817-22.
3
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.启动子高甲基化是肝吸虫相关胆管癌中hMLH1基因失活的主要事件。
Cancer Lett. 2005 Jan 20;217(2):213-9. doi: 10.1016/j.canlet.2004.06.020.
4
Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.RUNX3基因启动子高甲基化在食管鳞状细胞癌中的作用
Cancer Invest. 2007 Dec;25(8):685-90. doi: 10.1080/07357900701561131.
5
Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.滋养层细胞表面抗原2的抑制增强了肝吸虫相关性胆管癌的增殖和迁移。
Ann Hepatol. 2016 Jan-Feb;15(1):71-81. doi: 10.5604/16652681.1184223.
6
Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.胆管癌中1p36微卫星改变的预后意义
World J Gastroenterol. 2006 Jul 21;12(27):4377-82. doi: 10.3748/wjg.v12.i27.4377.
7
Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.亲环蛋白 A 增强肝吸虫相关胆管癌的细胞增殖和肿瘤生长。
Mol Cancer. 2011 Aug 26;10:102. doi: 10.1186/1476-4598-10-102.
8
Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer.人胰腺癌中1p36处RUNX3基因表观遗传失活的不良预后
Br J Cancer. 2008 May 20;98(10):1690-5. doi: 10.1038/sj.bjc.6604333. Epub 2008 May 13.
9
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.微卫星不稳定散发性结肠癌中RUNX3的表观遗传失活
Int J Cancer. 2004 Dec 10;112(5):754-9. doi: 10.1002/ijc.20472.
10
Liver fluke induces cholangiocarcinoma.肝吸虫诱发胆管癌。
PLoS Med. 2007 Jul;4(7):e201. doi: 10.1371/journal.pmed.0040201.

引用本文的文献

1
Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.用于肝细胞癌和胆管癌鉴别诊断的独特染色体异常模式。
PLoS One. 2025 May 12;20(5):e0322408. doi: 10.1371/journal.pone.0322408. eCollection 2025.
2
Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.在原发性硬化性胆管炎患者中检测胆管癌——DNA甲基化和分子生物标志物的前景
JHEP Rep. 2020 Jul 11;2(5):100143. doi: 10.1016/j.jhepr.2020.100143. eCollection 2020 Oct.
3
Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations.
根据突变相对丰度和拷贝数改变定义的两类肝内胆管癌。
Oncotarget. 2016 Apr 26;7(17):23825-36. doi: 10.18632/oncotarget.8183.
4
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.胆管癌诊断、预后和治疗的分子生物标志物的组学视角
Int J Genomics. 2015;2015:179528. doi: 10.1155/2015/179528. Epub 2015 Sep 2.
5
Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.肝内胆管癌的染色体拷贝数改变模式
BMC Cancer. 2015 Mar 14;15:126. doi: 10.1186/s12885-015-1111-6.
6
Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer.癌症中与转化生长因子-β(TGF-β)信号转导相关的基因的 DNA 启动子超甲基化导致的表观遗传改变。
Cancers (Basel). 2011 Mar 3;3(1):982-93. doi: 10.3390/cancers3010982.
7
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.肝内胆管癌:发病机制与分子治疗策略。
Oncogene. 2013 Oct 10;32(41):4861-70. doi: 10.1038/onc.2012.617. Epub 2013 Jan 14.
8
Aberrant DNA methylation profile in cholangiocarcinoma.胆管癌中异常的DNA甲基化图谱。
World J Gastrointest Pathophysiol. 2010 Jun 15;1(2):23-9. doi: 10.4291/wjgp.v1.i2.23.